Compendia Bioscience ( and Ingenuity Systems ( decided to integrate their flagship products Oncomine™ Professional and Ingenuity Pathways Analysis (IPA). The resulting products will allow users to navigate directly from cancer gene signatures discovered in Oncomine Professional to the curated pathway information available on IPA.
Oncomine Professional is a compendium of transcriptome profiles coupled with analysis functions and a web application for data mining and visualization. Ingenuity Pathways Analysis is a software application that enables identification of biological mechanisms, pathways, and functions.

Previous articleAccess Pharmaceuticals Hones in on Oncology Focus with Acquisition
Next articleTorreyPines and Eisai Renew Alzheimer’s Partnership